You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (4) |
Back to Search
Chinese expert consensus of the prescription audit for antitumor drugs-lung Cancer
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-029
- By: GUOHUI, Li (National Cancer Center/Cancer Hospital, Chinese Academy of, Department of Pharmacy, China)
- Co-author(s): Li Guohui: Department of Pharmacy, National Cancer Center/Cancer Hospital, Chinese Academy of, Beijing, China
Min Liu: Department of Pharmacy, National Cancer Center/Cancer Hospital, Chinese Academy of, Beijing, China - Abstract:
Background
Primary lung cancer is the most malignant tumor with the highest incidence and mortality in China.MDT (Multidisciplinary Team), as well as individualized treatment, is normally used for most cases. However, for whichever treatment is adopted, drug is indispensable.Purpose
To standardize the drug therapy of tumor, improve the prognosis.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026